Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 13 | $111,198,414 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Sep 2024 21:00 | VRDN | Viridian Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 13 Sep 2024 | Purchase | 1,600,000 | 18.75 | 30,000,000 | I |
17 Sep 2024 20:56 | ZBIO | Zenas BioPharma Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 16 Sep 2024 | Purchase A | 300,000 | 17 | 5,100,000 | I |
16 Sep 2024 20:54 | ZBIO | Zenas BioPharma Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 16 Sep 2024 | Purchase | 300,000 | 17 | 5,100,000 | I |
24 Jan 2024 18:44 | VRDN | Viridian Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 22 Jan 2024 | Purchase | 476,190 | 21 | 9,999,990 | I |
03 Oct 2023 16:00 | DNTH | Dianthus Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 29 Sep 2023 | Purchase | 24,670 | 13.63 | 336,252 | I |
28 Sep 2023 17:09 | DNTH | Dianthus Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 26 Sep 2023 | Purchase | 30,000 | 13.15 | 394,500 | I |
21 Sep 2023 16:23 | DNTH | Dianthus Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 19 Sep 2023 | Purchase | 30,000 | 13.2 | 396,000 | I |
13 Sep 2023 21:17 | DNTH | Dianthus Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 13 Sep 2023 | Purchase | 9,367 | 11.76 | 110,156 | I |
13 Sep 2023 21:17 | DNTH | Dianthus Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director , 10% | 12 Sep 2023 | Purchase | 14,887 | 10.85 | 161,524 | I |
17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 13 Jul 2023 | Purchase | 892,529 | 17 | 15,172,993 | I |
17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 13 Jul 2023 | Purchase | 1,992,734 | 17 | 33,876,478 | I |
17 Jul 2023 20:00 | APGE | Apogee Therapeutics Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | Director | 13 Jul 2023 | Purchase | 55,913 | 17 | 950,521 | I |
13 Jun 2023 16:07 | COGT | Cogent Biosciences Inc | FAIRMOUNT FUNDS MANAGEMENT LLC | 10% | 09 Jun 2023 | Purchase | 800,000 | 12 | 9,600,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)